Remove 2030 Remove Drug Research Remove Research
article thumbnail

Pfizer, looking for a jumpstart, leans into cancer drug research

BioPharma Drive: Drug Pricing

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

article thumbnail

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. billion by 2030 at a compound annual growth rate (CAGR) of 7.5% What is a Pre-Clinical CRO?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Possible adulticidal drugs for Onchocerca volvulus

Drug Target Review

Introduction I clearly remember an incident as a researcher, which kept happening, from my undergraduate research up till now. Summary of research The undergraduate study concentrated on the potential adulticidal effects of oral analgesics (acetaminophen, aspirin, and ibuprofen) on Onchocerca volvulus. doi: 10.1002/14651858.CD011146.pub2.

Drugs 105
article thumbnail

World Malaria Day 2021

The Pharma Data

Novartis is advancing Research & Development of next-generation treatments to combat emerging drug resistance. As part of the PAMAfrica research consortium led by Medicines for Malaria Venture, we also initiated the development of a new formulation of our ACT for infants weighing less than 5 kilograms. Read the reports.